US Stock MarketDetailed Quotes

ABVX Abivax S.A.

Watchlist
  • 14.295
  • +0.345+2.47%
Close Jun 7 16:00 ET
899.25MMarket Cap-3827P/E (TTM)

About Abivax S.A. Company

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Company Profile

SymbolABVX
Company NameAbivax S.A.
Issue Price11.60
Founded2013
CEOMr. Marc de Garidel
MarketNASDAQ
Employees61
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address7-11 Boulevard Haussmann
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75009
Phone33-1-53-83-09-63
Websitehttp://www.abivax.com

Company Executives

  • Name
  • Position
  • Salary
  • Marc de Garidel
  • Chief Executive Officer and Chairman of the Board
  • --
  • Sheldon Sloan
  • Chief Medical Officer
  • --
  • Didier Scherrer
  • Chief Scientific Officer
  • --
  • Ida Hatoum
  • Chief People Officer
  • --
  • Pierre Courteille
  • Chief Business Officer
  • --
  • Didier Blondel
  • Chief Financial Officer and Secretary of the Board
  • --
  • Michael Ferguson
  • Chief Commercial Officer
  • --
  • Dr. Philippe Pouletty
  • Director
  • --
  • Dr. June Lee, M.D.
  • Independent Director
  • --
  • Camilla Soenderby
  • Independent Director
  • --
  • Troy A. Ignelzi
  • Independent Director
  • --
  • Corinna zur Bonsen-Thomas
  • Independent Director
  • --
  • Kinam Hong
  • Independent Director
  • 10.20K
  • Dr. Carol L. Brosgart, M.D.
  • Independent Director
  • 18.53K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg